Related Experiment Videos
Carotid sinus hypersensitivity: evaluation of the vasodepressor component
Circulation
|May 1, 1985
Summary
Atrioventricular sequential pacing and certain medications do not prevent vasodepressor responses in carotid sinus hypersensitivity (CSH). Vasoconstrictors like ephedrine, however, can significantly attenuate these responses.
Area of Science:
- Cardiology
- Clinical Electrophysiology
- Pharmacology
Background:
- The underlying mechanisms of vasodepressor responses in patients with carotid sinus hypersensitivity (CSH) remain unclear.
- Effective strategies for preventing recurrent hypotension induced by vasodepressor responses in CSH patients are lacking.
Purpose of the Study:
- To evaluate the efficacy of atrioventricular sequential pacing and pharmacological interventions in preventing carotid sinus massage (CSM)-induced vasodepressor responses in CSH patients.
Main Methods:
- Eight patients with CSH underwent carotid sinus massage (CSM) under various conditions: control, atrioventricular sequential pacing (maintaining heart rate at 80 bpm and atrioventricular interval at 150 ms), pharmacologic blockade (atropine, atropine plus propranolol), and administration of vasoconstrictors (norepinephrine, ephedrine).
- Systolic blood pressure changes following CSM were measured and compared across different interventions.
Main Results:
- Atrioventricular sequential pacing did not significantly alter the mean fall in systolic pressure induced by CSM.
- Pharmacological blockade with atropine or combined atropine and propranolol also failed to significantly attenuate the CSM-induced drop in systolic pressure.
- Intravenous norepinephrine and oral ephedrine significantly blunted the CSM-induced decrease in systolic pressure (p < .01 compared to pacing alone).
Conclusions:
- Atrioventricular sequential pacing alone is insufficient to prevent hypotension in CSH patients with significant vasodepressor responses.
- Pharmacological muscarinic blockade or combined adrenergic blockade does not effectively prevent these responses.
- Vasoconstrictors, particularly alpha-adrenergic agonists like ephedrine, show promise in attenuating CSM-induced vasodepressor responses and may help diminish symptoms in CSH patients.